Gennex Laboratories - GENNEX, 531739 corporate action history

Gennex Laboratories Ltd.

BSE: 531739 |

Mid-range Performer

Download real time

11.77 -0.34 (-2.81%)

31.77% Fall from 52W High

618.5K

BSE Volume

BSE 27 May, 2026 3:31 PM (IST)

Board Meeting

The next board meeting for Gennex Laboratories is on 30 May 2026 for the purpose of Audited Results See details

Gennex Laboratories Bonus history

Gennex Laboratories has not announced any bonus since Jan 1, 2000.

See all forthcoming Bonus and Splits

Split history for Gennex Laboratories

Gennex Laboratories has split the face value 1 time since Dec. 14, 2009. Gennex Laboratories had last split the face value of its shares from ₹10 to ₹1 in 2009.The share has been quoting on an ex-split basis from Dec. 14, 2009.

Ex-Date	Old FV	New FV	Record Date
14 Dec 2009	10	1	15 Dec 2009

See all forthcoming Bonus and split

Gennex Laboratories Dividend history

Gennex Laboratories has not given any dividends since Jan 1, 2000.

See all forthcoming dividends

Board Meetings - Gennex Laboratories

The next board meeting for Gennex Laboratories is on 30 May 2026 for the purpose of Audited Results

Ex-Date	Purpose	Notes
30 May 2026	Audited Results	-
16 Apr 2026	Others	Inter-alia, to consider 1. Decide regarding the conduct of EGM for Regularization of Additional Director Ms. Khushbu Kachhawa as a Director. 2. Appoint Scrutinizer for EGM. 3. Other business matters.
14 Feb 2026	Quarterly Results	-
14 Nov 2025	Quarterly Results	-
04 Sep 2025	A.G.M.	-
14 Aug 2025	Quarterly Results	-
30 May 2025	Audited Results	-
14 Feb 2025	Quarterly Results	-
14 Nov 2024	Quarterly Results & Others	-
14 Aug 2024	Quarterly Results	-

See all Board Meetings for Gennex Laboratories

Rights history for Gennex Laboratories

Gennex Laboratories issued rights 1 time since July 21, 2022. Gennex Laboratories had last issued Rights shares of ₹1.0/- in the ratio of 1.0:2.0 @ premium of ₹5.0/- on July 21, 2022.

Ex-Date	Ratio	Face Value	Premium	Record Date
21 Jul 2022	1.0:2.0	1.0	5.0	22 Jul 2022

See all Rights History for Gennex Laboratories

Is Gennex Laboratories Ltd. worth buying?

131 Votes:

Buy 83.21%

Sell 6.87%

Hold 9.92%